LATEST NEWS
Analgesics (Narcotic/Non-Narcotic)
QRxPharma Announces Interim Analysis of Final Pivotal Phase 3 Study for MoxDuo IR
from PharmaLive - September 2, 2010
Antimicrobials (Antibiotics)
FDA MedWatch - Tygacil (tigecycline): Label Change - Increased Mortality Risk
from PharmaLive - September 2, 2010
Cardiovasculars (Stroke)
Double-Dose Plavix Benefits Certain Patients, Study Finds
from Drugs.com - September 2, 2010
CNS (Antiobesity)
Diet Pill Meridia Ups Heart Attack Risk: Study
from Drugs.com - September 2, 2010
CNS (Neurologics [MS])
Most Neurologists Plan to Prescribe Oral Multiple Sclerosis Drugs, but Will Proceed with Caution
from PharmaLive - September 2, 2010
Hormones (Diabetes)
Novo Nordisk Creates “App” to Help Doctors Dose Insulin
from PharmaLive - September 2, 2010
Oncology
Roche Provides Update on FDA Application for T-DM1
from Medical News TODAY - September 2, 2010
Respiratory/Allergy (Asthma)
From Oranienburg to the Rest of the World: Global Market Launch of Daxas® (Roflumilast) Kicks Off in Germany
from PharmaLive - September 2, 2010
COMPANY NEWS
New Detail Snapshot Studies available for all markets. Compare our offerings to your current monthly tracker. Competitively priced for a great fit into your tight budgets. Custom questions and sampling welcome.
PRESS RELEASES
7.26.10 New Study Shows That 73% of Primary Care Physicians Favor Samples Provided by Sales Representatives Over Other Methods, Including E-sampling
7.26.10 Ongoing Study Shows That 87% of Physicians Believe Risks Are Associated With The Use of LABAs
THIS WEEK'S NEWS
Analgesics (Narcotic/Non-Narcotic)
Pivotal Phase 3 Study Compares Tapentadol Extended Release Tablets to Placebo in Patients with Chronic Osteoarthritis Knee Pain
from Drugs.com - September 1, 2010
Analgesics (NSAIDs)
Pre and Post-Operative Use of Caldolor (Ibuprofen) Injection Significantly Reduces Pain and Opioid Use in Newly Published Study
from Drugs.com - September 1, 2010
Cardiovasculars (Cholesterol)
Mipomersen Phase 3 Trial Meets Primary Endpoint: Genzyme, Isis Pharma
from Pharmaceutcial Business Review - September 1, 2010
Review Finds No Statin-Cancer Link
from Drugs.com - September 1, 2010
Cardiovasculars (Stroke)
Rivaroxaban Successfully Demonstrated Non-Inferiority Compared to Standard of Care for the Prevention of Recurrent Venous Thromboembolism in Pivotal Phase 3 Study
from PharmaLive - September 1, 2010
CNS (Alcohol/Drug Dependence)
MonoSol Rx Announces Reckitt Benckiser FDA Approval of Suboxone Sublingual Film for Treatment of Opioid Dependence
from PharmaLive - September 1, 2010
CNS (Antidepressants)
New Data Supports Valdoxan’s Unique Clinical Signature
from PharmaLive - September 1, 2010
Hormones (Menopause/ERT/HRT)
Bionovo Receives Positive Guidance from FDA on Menerba
from PharmaLive - September 1, 2010
Support our troops. Please donate to:
